Advertisement

Japan's Nippon Foundation helps in tackling Hansen's disease in India

Follow The Hawk on Google News+ Follow

Advertisement


Tokyo: The Japan-based Nippon Foundation has regularly helped India in tackling the Hansen's disease, also known as leprosy that can damage the nervous system and result in crippling of hands and feet, paralysis, as well as blindness if left untreated.

Renowned online medical journal 'The Lancet' referred to the book "No Matter Where the Journey Takes Me" written by Yohei Sasakawa, the chairman of the foundation. The book recollected Sasakawa's experiences of combating the Hansen's disease during his visit to some 90 countries, including India.

Advertisement

Sasakawa visited India 60 times to cooperate in activities tackling Hansen's disease. His visit in the beginning of this year was distinctively memorable.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

India has the largest number of patients infected by Hansen's disease, estimating roughly over 120,000. It occupies 60 per cent of the total tally globally.

The Nippon Foundation's branch in Delhi has regularly held events to aware people of the dangerous disease, such as observing "Anti-Leprosy Day 2020".

Advertisement

In Gujarat, the Nippon Foundation has been supporting local association partners such as APAL to make people aware of the disease spread.

Volunteers working with 'ASHA' group, wearing orange-colored saris detect leprosy patients visiting the area. Sasakawa encourages the health group to recognize patients infected with the disease who usually tend to hide.

In 2018, Sasakawa was also awarded the Gandhi Peace prize keeping in view his contribution to combating the disease. (ANI)

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST